Home › Compare › BMCS vs NOBL

BMCS vs NOBL: Dividend Comparison 2026

BMCS yields 181818.18% · NOBL yields 2.17%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BMCS wins by $1.8951031795759825e+29M in total portfolio value
10 years
BMCS
BMCS
● Live price
181818.18%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.8951031795759825e+29M
Annual income
$189,305,502,041,192,720,000,000,000,000,000,000.00
Full BMCS calculator →
NOBL
NOBL
● Live price
2.17%
Share price
$104.67
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.78
Full NOBL calculator →

Portfolio growth — BMCS vs NOBL

📍 BMCS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBMCSNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BMCS + NOBL cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BMCS pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMCS
Annual income on $10K today (after 15% tax)
$15,454,545.45/yr
After 10yr DRIP, annual income (after tax)
$160,909,676,735,013,800,000,000,000,000,000,000.00/yr
NOBL
Annual income on $10K today (after 15% tax)
$184.52/yr
After 10yr DRIP, annual income (after tax)
$212.31/yr
At 15% tax rate, BMCS beats the other by $160,909,676,735,013,800,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMCS + NOBL for your $10,000?

BMCS: 50%NOBL: 50%
100% NOBL50/50100% BMCS
Portfolio after 10yr
$9.475515897879912e+28M
Annual income
$94,652,751,020,596,360,000,000,000,000,000,000.00/yr
Blended yield
99.89%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMCS buys
0
NOBL buys
0
No recent congressional trades found for BMCS or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBMCSNOBL
Forward yield181818.18% ✓2.17%
Annual dividend / share$2.00$2.27 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$1.8951031795759825e+29M$22.9K ✓
Annual income after 10y$189,305,502,041,192,720,000,000,000,000,000,000.00 ✓$249.78
Total dividends collected$1.8949690612486723e+29M$2.3K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: BMCS vs NOBL ($10,000, DRIP)

YearBMCS PortfolioBMCS Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$18,192,518$18,181,818.18$10,917$217.08+$18.18M → BMCS
2$30,932,835,887$30,913,369,892.64$11,903$221.48+$30932.82M → BMCS
3$49,156,619,660,049$49,123,521,525,649.34$12,962$225.68+$49156619.65M → BMCS
4$73,009,768,971,452,110$72,957,171,388,415,860.00$14,099$229.68+$73009768971.44M → BMCS
5$101,348,671,691,011,770,000$101,270,551,238,212,300,000.00$15,319$233.49+$101348671691011.75M → BMCS
6$131,490,628,941,834,950,000,000$131,382,185,863,125,600,000,000.00$16,628$237.10+$131490628941834960.00M → BMCS
7$159,445,709,700,484,420,000,000,000$159,305,014,727,516,640,000,000,000.00$18,033$240.53+$159445709700484431872.00M → BMCS
8$180,706,560,655,892,340,000,000,000,000$180,535,953,746,512,850,000,000,000,000.00$19,539$243.78+$1.8070656065589233e+23M → BMCS
9$191,416,744,304,199,340,000,000,000,000,000$191,223,388,284,297,560,000,000,000,000,000.00$21,154$246.86+$1.9141674430419936e+26M → BMCS
10$189,510,317,957,598,240,000,000,000,000,000,000$189,305,502,041,192,720,000,000,000,000,000,000.00$22,884$249.78+$1.8951031795759825e+29M → BMCS

BMCS vs NOBL: Complete Analysis 2026

BMCS — Stock

BioTech Medics, Inc. operates as a medical-based holding company. The company operates medical therapeutic laser centers that treat various pain ailments affecting the muscles, nerves, and bones, as well as arthritis. It also offers SHBAN, an antiseptic hand and body sanitizer. In addition, the company develops and sells nutraceutical products, such as BioBody Balance, a liquid vitamin concentrate; and BioBody Energy Spray, a caffeine and alcohol free natural vitamin energy spray. It offers its nutraceutical products through gross retail sales. The company was incorporated in 1997 and is based in Southlake, Texas with laser pain centers in Texas, California, New Mexico, and Florida.

Full BMCS Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this BMCS vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMCS vs SCHDBMCS vs JEPIBMCS vs OBMCS vs KOBMCS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.